Titan Medical Inc.

Titan Medical Inc.

July 29, 2008 12:28 ET

Titan Medical Inc. Announces Completion of Qualifying Transaction

TORONTO, ONTARIO--(Marketwire - July 29, 2008) - Titan Medical Inc. (formerly known as KAM Capital Corp.) (the "Corporation") (TSX VENTURE:TMD), is pleased to announce that it has completed its qualifying transaction (the "Transaction") with Synergist Medical Inc. ("Synergist"), pursuant to the policies of the TSX Venture Exchange (the "Exchange"). The common shares of the Corporation will resume trading on July 30, 2008. The Transaction was previously described in the May 6, 2008 and June 25, 2008 press releases of the Corporation and a Filing Statement in respect of the Transaction was filed on SEDAR on July 17, 2008.

Pursuant to the Transaction, 2174656 Ontario Limited, a special purpose wholly-owned subsidiary of what was then known as KAM Capital Corp., changed its name to Titan Medical Inc. and then amalgamated with Synergist. This amalgamated entity then amalgamated with KAM Capital Corp. and now continues on business as Titan Medical Inc. Pursuant to the Transaction, a total of 26,032,631 common shares of the Corporation were issued in exchange for shares of Synergist. 13,874,165 of these shares are subject to escrow pursuant to the policies of the Exchange and will be released from escrow in six-month intervals over a period of three years from closing of the Transaction.

The Corporation now has 33,283,630 common shares outstanding. In addition, following the Transaction, 1,165,050 options to purchase common shares of the Corporation were granted to officers, directors, employees and consultants of the Corporation.

Directors and Officers

The directors of the Corporation are Dr. Reiza Rayman, Craig Leon, William Jackson and Martin C. Bernholtz.

The officers of the Corporation are Dr. Rayman as President, Mr. Leon as Chief Executive Officer and Joe Yukich as Chief Financial Officer.

Resumption of Trading

The Exchange has issued a bulletin advising that the Corporation has met the requirements to be listed on the Exchange as a Tier 2 company and that trading in the common shares of the Corporation will resume at the opening on July 30, 2008, under the trading symbol TMD.

Early Warning

Pursuant to the Transaction, Dr. Reiza Rayman now holds 4,848,377 (14.6%) common shares, Craig Leon now holds 4,177,411 (12.6%) common shares and John Unsworth holds 4,848,377 (14.6%) common shares of the Corporation.

About the Corporation

The Corporation is committed to developing a 3-armed robotic surgical system to permit surgeons to remotely manipulate surgical instruments. Robotic surgery has developed over the past ten years into a proven and growing method of treatment. Titan Medical Inc. plans to use new, innovative technologies to empower surgeons using robots. From enhanced control to better communications, Titan is researching technologies for the operating room of the future.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information